Cardiac Natriuretic Peptide Profiles in Chronic Hypertension by Single or Sequentially Combined Renovascular and

Carolina S Cerrudo1, Susana Cavallero1, Martín Rodríguez Fermepín1

  • 1Facultad de Farmacia y Bioquímica, Cátedras de Fisiopatología y Anatomía e Histología, Universidad de Buenos Aires, Buenos Aires, Argentina.

Insights

Natriuretic peptides like ANP and BNP show differential gene expression during cardiac remodeling. Volume overload impacts ANP more, while pressure overload affects BNP in hypertrophied ventricles.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cardiology

Background:

  • Chronic hemodynamic overload induces cardiac hypertrophy and remodeling.
  • Natriuretic peptides, including atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), play roles in cardiovascular homeostasis.
  • Understanding the differential regulation of ANP and BNP during distinct overload conditions is crucial for cardiovascular research.

Purpose of the Study:

  • To investigate the involvement of natriuretic peptides during hypertrophic remodeling.
  • To compare the effects of pressure overload (renovascular hypertension) and volume overload (DOCA-salt) on cardiac hypertrophy and natriuretic peptide gene expression.
  • To examine the impact of sequential combined overload models on these parameters.

Main Methods:

  • Induction of hypertension in rats using renovascular (pressure overload) and DOCA-salt (volume overload) models for 6 and 12 weeks.
  • Assessment of cardiac hypertrophy and left ventricular ANP and BNP gene expression.
  • Evaluation of combined sequential overload models (RV/DS and DS/RV).

Main Results:

  • Both single and combined overload models induced hypertension and cardiac hypertrophy.
  • Cardiac hypertrophy and ANP gene expression were more pronounced in the DOCA-salt (volume overload) group compared to the renovascular (pressure overload) group.
  • BNP gene expression correlated with hypertrophy in pressure overload, while ANP correlated with hypertrophy in volume overload.
  • Sequential combined overload showed intermediate effects, with the second stimulus being less potent than the first.

Conclusions:

  • Volume and pressure overload differentially regulate ANP and BNP gene expression in hypertrophied left ventricles.
  • ANP synthesis is suggested to correlate with volume overload, while BNP synthesis correlates with pressure overload-induced hypertrophy.
  • Plasma ANP levels reflect volume changes, whereas circulating BNP levels are linked to cardiac synthesis and ventricular hypertrophy.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
635
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
284
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
576
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
133
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
60
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
1.9K